RECURSION PHARMACEUTICALS-A
RXRXNASDAQ🏆 #1941 by market capEarnings Nov 3US Equity
$4.03▲ $0.36 (+8.92%)
🌙 After hours$4.05▲ 0.49%Regular close · extended-hours price shownTrack RXRX
Get earnings, price moves & breaking news on Telegram
24h▲ 8.9%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$2.11B
Small Cap
📈Revenue Growth (YoY)
+26.9%
High Growth
📊Gross Margin
-46.7%
Thin
💵FCF Margin
-645.8%
Thin
⚖️P/S Ratio
38.5x
Expensive
Otter Score
64
Fair
RECURSION PHARMACEUTICALS-A
RXRXAnalyst Ratings
Price
$4.03
Total
10
Raised
0
Lowered
0
Avg PT
$5.30
H / L
$5 / $5
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Morgan Stanley | Reiterated | Equal Weight | 2026-05-14 | $5.30 | +31.50% |
Needham | Reiterated | Buy | 2026-05-07 | $11.00 | +173.00% |
JP Morgan | Reiterated | Overweight | 2026-04-30 | — | — |
B of A Securities | Reiterated | Neutral | 2026-02-26 | — | — |
Leerink Partners | Reiterated | Market Perform | 2025-02-28 | $6.00 | +48.90% |
Keybanc | Reiterated | Overweight | 2025-01-08 | $12.00 | +197.80% |
Jefferies | Reiterated | Hold | 2024-09-03 | $6.00 | +48.90% |
Berenberg | Reiterated | Buy | 2023-07-12 | — | — |
SVB Leerink | Reiterated | Market Perform | 2023-01-23 | — | — |
Goldman Sachs | Reiterated | Neutral | 2022-11-09 | — | — |
Institution
Morgan Stanley
Reiterated · Equal Weight · 2026-05-14
$5.30
+31.50%
Needham
Reiterated · Buy · 2026-05-07
$11.00
+173.00%
JP Morgan
Reiterated · Overweight · 2026-04-30
—
—
B of A Securities
Reiterated · Neutral · 2026-02-26
—
—
Leerink Partners
Reiterated · Market Perform · 2025-02-28
$6.00
+48.90%
Keybanc
Reiterated · Overweight · 2025-01-08
$12.00
+197.80%
Jefferies
Reiterated · Hold · 2024-09-03
$6.00
+48.90%
Berenberg
Reiterated · Buy · 2023-07-12
—
—
SVB Leerink
Reiterated · Market Perform · 2023-01-23
—
—
Goldman Sachs
Reiterated · Neutral · 2022-11-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space